Schimke immuno-osseous dysplasia is a rare multisystemic disorder caused by biallelic loss of function of the SMARCAL1 gene that plays a pivotal role in replication fork stabilization and thus DNA repair. Individuals affected from this disease suffer from disproportionate growth failure, steroid resistant nephrotic syndrome leading to renal failure and primary immunodeficiency mediated by T cell lymphopenia. With infectious complications being the leading cause of death in this disease, researching the nature of the immunodeficiency is crucial, particularly as the state is exacerbated by loss of antibodies due to nephrotic syndrome or immunosuppressive treatment. Building on previous findings that identified the loss of IL-7 receptor expression as a possible cause of the immunodeficiency and increased sensitivity to radiation-induced damage, we have employed spectral cytometry and multiplex RNA-sequencing to assess the phenotype and function of T cells ex-vivo and to study changes induced by in-vitro UV irradiation and reaction of cells to the presence of IL-7. Our findings highlight the mature phenotype of T cells with proinflammatory Th1 skew and signs of exhaustion and lack of response to IL-7. UV light irradiation caused a severe increase in the apoptosis of T cells, however the expression of the genes related to immune response and regulation remained surprisingly similar to healthy cells. Due to the disease's rarity, more studies will be necessary for complete understanding of this unique immunodeficiency.

Department of Immunology 2nd Faculty of Medicine Charles University and University Hospital in Motol Prague Czech Republic

Department of Internal Medicine 2nd Faculty of Medicine Charles University and University Hospital in Motol Prague Czech Republic

Department of Pediatrics 2nd Faculty of Medicine Charles University and University Hospital in Motol Prague Czech Republic

See more in PubMed

Poole LA, Cortez D. SMARCAL1 and telomeres: replicating the troublesome ends. Nucleus. 2016;7:270–4. PubMed PMC

Elizondo LI, Cho KS, Zhang W, Yan J, Huang C, Huang Y, et al. Schimke Immuno-osseous dysplasia: SMARCAL1 loss-of-function and phenotypic correlation. J Med Genet. 2009;46:49–59. PubMed

Zieg J, Bezdíčka M, Němčíková M, Balaščáková M, Suková M, Štěrbová K, et al. Schimke immunoosseous dysplasia: an ultra-rare disease. A 20-year case series from the tertiary hospital in the Czech Republic. Ital J Pediatr. 2023;49:11. PubMed PMC

Boerkoel CF, O’Neill S, André JL, Benke PJ, Bogdanovíć R, Bulla M, et al. Manifestations and treatment of Schimke Immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr. 2000;159:1–7. PubMed

Spranger J, Hinkel GK, Stöss H, Thoenes W, Wargowski D, Zepp F. Schimke Immuno-osseous dysplasia: a newly recognized multisystem disease. J Pediatr. 1991;119:64–72. PubMed

Kilic SS, Donmez O, Sloan EA, Elizondo LI, Huang C, André J-L, et al. Association of migraine-like headaches with Schimke Immuno-osseous dysplasia. Am J Med Genet A. 2005;135:206–10. PubMed

Lev A, Amariglio N, Levy Y, Spirer Z, Anikster Y, Rechavi G, et al. Molecular assessment of thymic capacities in patients with Schimke Immuno-osseous dysplasia. Clin Immunol. 2009;133:375–81. PubMed

Marin AV, Jiménez-Reinoso A, Mazariegos MS, Román-Ortiz E, Regueiro JR. T-cell receptor signaling in Schimke Immuno-osseous dysplasia is SMARCAL1-independent. Front Immunol. 2022;13:979722. PubMed PMC

Sanyal M, Morimoto M, Baradaran-Heravi A, Choi K, Kambham N, Jensen K, et al. Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke Immuno-osseous dysplasia (SIOD). Clin Immunol. 2015;161:355–65. PubMed

Pugliese GM, Salaris F, Palermo V, Marabitti V, Morina N, Rosa A, et al. Inducible SMARCAL1 knockdown in iPSC reveals a link between replication stress and altered expression of master differentiation genes. Dis Model Mech. 2019;12. 10.1242/dmm.039487. PubMed PMC

Piatosa B, Wolska-Kuśnierz B, Tkaczyk K, Heropolitanska-Pliszka E, Grycuk U, Wakulinska A, et al. T lymphocytes in patients with Nijmegen Breakage Syndrome demonstrate features of exhaustion and senescence in Flow Cytometric evaluation of Maturation Pathway. Front Immunol. 2020;11:1319. PubMed PMC

Klocperk A, Paračková Z, Bloomfield M, Rataj M, Pokorný J, Unger S, et al. Follicular Helper T Cells in DiGeorge Syndrome. Front Immunol. 2018;9:1–9. PubMed PMC

Postow L, Woo EM, Chait BT, Funabiki H. Identification of SMARCAL1 as a component of the DNA damage Response*. J Biol Chem. 2009;284:35951–61. PubMed PMC

Keka IS, Mohiuddin, Maede Y, Rahman MM, Sakuma T, Honma M, et al. Smarcal1 promotes double-strand-break repair by nonhomologous end-joining. Nucleic Acids Res. 2015;43:6359–72. PubMed PMC

Kuo LJ, Yang L-X. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. Vivo. 2008;22:305–9. PubMed

Ataide MA, Komander K, Knöpper K, Peters AE, Wu H, Eickhoff S, et al. BATF3 programs CD8 + T cell memory. Nat Immunol. 2020;21:1397–407. PubMed

Borges L, Kubin M, Kuhlman T. LIR9, an immunoglobulin-superfamily–activating receptor, is expressed as a transmembrane and as a secreted molecule. Blood. 2003;101:1484–6. PubMed

Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A. 2003;100:8856–61. PubMed PMC

Elias CG 3rd, Spellberg JP, Karan-Tamir B, Lin CH, Wang YJ, McKenna PJ, et al. Ligation of CD31/PECAM-1 modulates the function of lymphocytes, monocytes and neutrophils. Eur J Immunol. 1998;28:1948–58. PubMed

Nangia-Makker P, Nakahara S, Hogan V, Raz A. Galectin-3 in apoptosis, a novel therapeutic target. J Bioenerg Biomembr. 2007;39:79–84. PubMed PMC

Cullinan EB, Kwee L, Nunes P, Shuster DJ, Ju G, McIntyre KW, et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J Immunol. 1998;161:5614–20. PubMed

Mitchell K, Barreyro L, Todorova TI, Taylor SJ, Antony-Debré I, Narayanagari S-R, et al. IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med. 2018;215:1709–27. PubMed PMC

Lippner E, Lücke T, Salgado C, Boerkoel C, Lewis DB. Schimke Immunoosseous dysplasia. University of Washington, Seattle; 2023.

Clewing JM, Antalfy BC, Lücke T, Najafian B, Marwedel KM, Hori A, et al. Schimke Immuno-osseous dysplasia: a clinicopathological correlation. J Med Genet. 2007;44:122–30. PubMed PMC

Bertulli C, Marzollo A, Doria M, Di Cesare S, La Scola C, Mencarelli F, et al. Expanding phenotype of Schimke Immuno-Osseous dysplasia: congenital anomalies of the kidneys and of the urinary tract and alteration of NK cells. Int J Mol Sci. 2020;21. 10.3390/ijms21228604. PubMed PMC

Ma CS, Hodgkin PD, Tangye SG. Automatic generation of lymphocyte heterogeneity: Division-dependent changes in the expression of CD27, CCR7 and CD45 by activated human naive CD4 + T cells are independently regulated. Immunol Cell Biol. 2004;82:67–74. PubMed

Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E. The who’s who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol. 2013;43:2797–809. PubMed

Weber BN, Chi AW-S, Chavez A, Yashiro-Ohtani Y, Yang Q, Shestova O, et al. A critical role for TCF-1 in T-lineage specification and differentiation. Nature. 2011;476:63–8. PubMed PMC

Smetanova J, Milota T, Rataj M, Bloomfield M, Sediva A, Klocperk A. Accelerated maturation, exhaustion, and senescence of T cells in 22q11.2 deletion syndrome. J Clin Immunol. 2022;42:274–85. PubMed

Vladyka O, Vrabcova P, Reiterova M, Parackova Z, Haesler R, Sediva A, et al. Th1/interferon-γ bias in 22q11.2 deletion syndrome is driven by memory T cells and exacerbated by IL-7. Clin Immunol. 2023;256:109793. PubMed

Moxham VF, Karegli J, Phillips RE, Brown KL, Tapmeier TT, Hangartner R, et al. Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol. 2008;180:3910–8. PubMed

Schoop R, Wahl P, Le Hir M, Heemann U, Wang M, Wüthrich RP. Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol Dial Transpl. 2004;19:2713–20. PubMed

Bosticardo M, Pala F, Calzoni E, Delmonte OM, Dobbs K, Gardner CL, et al. Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020;4:2611–6. PubMed PMC

Bertaina A, Grimm PC, Weinberg K, Parkman R, Kristovich KM, Barbarito G, et al. Sequential stem cell–kidney transplantation in Schimke Immuno-osseous dysplasia. N Engl J Med. 2022;386:2295–302. PubMed PMC

Baradaran-Heravi A, Lange J, Asakura Y, Cochat P, Massella L, Boerkoel CF. Bone marrow transplantation in Schimke Immuno-osseous dysplasia. Am J Med Genet A. 2013;161A:2609–13. PubMed PMC

Baradaran-Heravi A, Raams A, Lubieniecka J, Cho KS, DeHaai KA, Basiratnia M, et al. SMARCAL1 deficiency predisposes to non-hodgkin lymphoma and hypersensitivity to genotoxic agents in vivo. Am J Med Genet A. 2012;158A:2204–13. PubMed PMC

Bansbach CE, Boerkoel CF, Cortez D. SMARCAL1 and replication stress: an explanation for. SIOD? Nucleus. 2010;1:245–8. PubMed PMC

Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022. 10.1007/s10875-022-01289-3. PubMed PMC

Pollard JM, Gatti RA. Clinical radiation sensitivity with DNA repair disorders: an overview. Int J Radiat Oncol Biol Phys. 2009;74:1323–31. PubMed PMC

Collins M-K, Peters K, English JC 3rd, Rady P, Tyring S, Jedrych J. Cutaneous squamous cell carcinoma with epidermodysplasia verruciformis-like features in a patient with Schimke immune-osseous dysplasia. J Cutan Pathol. 2018;45:465–7. PubMed